Association Between Female Sex and Better Survival in Gastroenteropancreatic Neuroendocrine Tumors
Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival and this difference would be greater in premenopausal age women...
Saved in:
| Published in | The Journal of surgical research Vol. 302; pp. 53 - 63 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.10.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival and this difference would be greater in premenopausal age women compared to older women.
The National Cancer Database from 2004 to 2016 was queried for patients with GEP-NETs based on histologic code. Demographic, tumor, treatment, and socioeconomic characteristics were compared between men and women and age ≤45 or >65 y using Fisher’s exact and Wilcoxon tests as appropriate. The primary endpoint was overall survival (OS), assessed by Kaplan–Meier survival analysis.
Included in the study were 73,521 patients with small bowel neuroendocrine tumors (SBNETs), gastric neuroendocrine tumors (GNETs), or pancreas neuroendocrine tumors (36,197 female, 37,324 male). Women lived longer regardless of primary site, with the largest difference in GNETs (median OS 139 versus 85 mo) and smallest in SBNETs (121 versus 116, P < 0.001 for both). While male patients more often had high grade and metastatic disease, female sex remained independently associated with improved OS after adjusting for confounders (hazard ratio 0.84, P < 0.001). In GNETs and SBNETs, female sex had a larger beneficial effect on OS in premenopausal than postmenopausal patients.
Women with GEP-NETs have improved survival over men, especially in the premenopausal age group. This may be due to a protective effect of female hormones; however, further studies are necessary to uncover the biologic basis of this difference. |
|---|---|
| AbstractList | Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival and this difference would be greater in premenopausal age women compared to older women.
The National Cancer Database from 2004 to 2016 was queried for patients with GEP-NETs based on histologic code. Demographic, tumor, treatment, and socioeconomic characteristics were compared between men and women and age ≤45 or >65 y using Fisher’s exact and Wilcoxon tests as appropriate. The primary endpoint was overall survival (OS), assessed by Kaplan–Meier survival analysis.
Included in the study were 73,521 patients with small bowel neuroendocrine tumors (SBNETs), gastric neuroendocrine tumors (GNETs), or pancreas neuroendocrine tumors (36,197 female, 37,324 male). Women lived longer regardless of primary site, with the largest difference in GNETs (median OS 139 versus 85 mo) and smallest in SBNETs (121 versus 116, P < 0.001 for both). While male patients more often had high grade and metastatic disease, female sex remained independently associated with improved OS after adjusting for confounders (hazard ratio 0.84, P < 0.001). In GNETs and SBNETs, female sex had a larger beneficial effect on OS in premenopausal than postmenopausal patients.
Women with GEP-NETs have improved survival over men, especially in the premenopausal age group. This may be due to a protective effect of female hormones; however, further studies are necessary to uncover the biologic basis of this difference. Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival and this difference would be greater in premenopausal age women compared to older women.INTRODUCTIONStudies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival and this difference would be greater in premenopausal age women compared to older women.The National Cancer Database from 2004 to 2016 was queried for patients with GEP-NETs based on histologic code. Demographic, tumor, treatment, and socioeconomic characteristics were compared between men and women and age ≤45 or >65 y using Fisher's exact and Wilcoxon tests as appropriate. The primary endpoint was overall survival (OS), assessed by Kaplan-Meier survival analysis.MATERIALS AND METHODSThe National Cancer Database from 2004 to 2016 was queried for patients with GEP-NETs based on histologic code. Demographic, tumor, treatment, and socioeconomic characteristics were compared between men and women and age ≤45 or >65 y using Fisher's exact and Wilcoxon tests as appropriate. The primary endpoint was overall survival (OS), assessed by Kaplan-Meier survival analysis.Included in the study were 73,521 patients with small bowel neuroendocrine tumors (SBNETs), gastric neuroendocrine tumors (GNETs), or pancreas neuroendocrine tumors (36,197 female, 37,324 male). Women lived longer regardless of primary site, with the largest difference in GNETs (median OS 139 versus 85 mo) and smallest in SBNETs (121 versus 116, P < 0.001 for both). While male patients more often had high grade and metastatic disease, female sex remained independently associated with improved OS after adjusting for confounders (hazard ratio 0.84, P < 0.001). In GNETs and SBNETs, female sex had a larger beneficial effect on OS in premenopausal than postmenopausal patients.RESULTSIncluded in the study were 73,521 patients with small bowel neuroendocrine tumors (SBNETs), gastric neuroendocrine tumors (GNETs), or pancreas neuroendocrine tumors (36,197 female, 37,324 male). Women lived longer regardless of primary site, with the largest difference in GNETs (median OS 139 versus 85 mo) and smallest in SBNETs (121 versus 116, P < 0.001 for both). While male patients more often had high grade and metastatic disease, female sex remained independently associated with improved OS after adjusting for confounders (hazard ratio 0.84, P < 0.001). In GNETs and SBNETs, female sex had a larger beneficial effect on OS in premenopausal than postmenopausal patients.Women with GEP-NETs have improved survival over men, especially in the premenopausal age group. This may be due to a protective effect of female hormones; however, further studies are necessary to uncover the biologic basis of this difference.CONCLUSIONSWomen with GEP-NETs have improved survival over men, especially in the premenopausal age group. This may be due to a protective effect of female hormones; however, further studies are necessary to uncover the biologic basis of this difference. |
| Author | Chan, Carlos H.F. Sherman, Scott K. Howe, James R. Tran, Catherine G. Chang, Jeremy Ear, Po Hien Suraju, Mohammed O. |
| Author_xml | – sequence: 1 givenname: Jeremy orcidid: 0000-0003-4281-9666 surname: Chang fullname: Chang, Jeremy organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 2 givenname: Mohammed O. surname: Suraju fullname: Suraju, Mohammed O. organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 3 givenname: Catherine G. surname: Tran fullname: Tran, Catherine G. organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 4 givenname: Carlos H.F. surname: Chan fullname: Chan, Carlos H.F. organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 5 givenname: Po Hien surname: Ear fullname: Ear, Po Hien organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 6 givenname: James R. surname: Howe fullname: Howe, James R. organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa – sequence: 7 givenname: Scott K. orcidid: 0000-0003-4903-0422 surname: Sherman fullname: Sherman, Scott K. email: Scott-sherman@uiowa.edu organization: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39083906$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kE9v1DAQxS1URLeFD8AF-cglYRzbcSxOpaJ_pAoOLWfLa08krxJ7sZMtfHu82sKRw2g0T2-e9H4X5CymiIS8Z9AyYP2nXbsrpe2gEy2oFlj3imwYaNkMveJnZAPQdY0YQJyTi1J2UG-t-BtyzjUMdfoN2V6VklywS0iRfsHlGTHSG5zthPQRf1Eb_VFeMNPHNR_CwU40RHpry5ITxqqnvY0uY01w9BuuR9Unl0NE-rTOKZe35PVop4LvXvYl-XHz9en6rnn4fnt_ffXQuI7LpUHGxShHpxQoLQfVexDSu0Eqq_TgR4vediC3im356PjgNHrQta7oNXIr-SX5eMrd5_RzxbKYORSH02QjprUYDkOvpRBaVCs7WV1OpWQczT6H2ebfhoE5ojU7U9GaI1oDylS09efDS_y6ndH_-_jLsho-nwxYSx4CZlNcwOjQh4xuMT6F_8T_Abk9jJc |
| Cites_doi | 10.1007/s11912-021-01172-1 10.1002/jso.26285 10.3390/cancers15061863 10.1001/jamaoncol.2016.6905 10.1093/annonc/mdq022 10.1093/annonc/mdz256.024 10.1111/jne.12967 10.1210/me.2004-0390 10.1002/cncr.11105 10.1210/er.2018-00160 10.1159/000319784 10.1002/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X 10.1002/jso.25731 10.1097/MPA.0000000000001821 10.1080/01621459.1958.10501452 10.1210/clinem/dgac001 10.1097/MPA.0000000000001981 10.1056/NEJM198107023050114 10.1038/nrc2795 10.1245/s10434-020-09566-4 10.1007/s11605-022-05345-6 10.3389/fonc.2022.955166 10.21037/tau.2016.11.16 10.1016/j.clcc.2015.12.007 10.1093/annonc/mdz414 10.1159/000326820 10.1097/MPA.0000000000000203 10.1245/s10434-021-09641-4 10.7326/0003-4819-96-3-383_1 10.1002/1097-0142(19800115)45:2<293::AID-CNCR2820450216>3.0.CO;2-5 10.1111/j.2517-6161.1972.tb00899.x 10.1002/ijc.31589 10.1245/s10434-021-10774-9 10.1001/jamaoncol.2017.0589 10.4132/jptm.2017.03.19 10.1111/jne.13309 10.5858/arpa.2013-0195-OA 10.4062/biomolther.2018.103 10.1001/jamanetworkopen.2021.24750 10.1007/s13193-020-01079-6 10.2741/1685 10.1038/modpathol.2012.143 10.3390/cancers15102766 10.1093/oncolo/oyac049 10.1634/theoncologist.2019-0466 10.20452/pamw.2832 |
| ContentType | Journal Article |
| Copyright | 2024 Published by Elsevier Inc. |
| Copyright_xml | – notice: 2024 – notice: Published by Elsevier Inc. |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.jss.2024.07.012 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1095-8673 |
| EndPage | 63 |
| ExternalDocumentID | 10_1016_j_jss_2024_07_012 39083906 S0022480424003937 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABFNM ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEK HMK HMO HVGLF HZ~ IHE J1W J5H KOM LG5 M29 M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K UHS WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c235t-e134f5fc770795876d045dc857a798dfaeda205b71b3fc38c9ed09109469e3a53 |
| IEDL.DBID | AIKHN |
| ISSN | 0022-4804 1095-8673 |
| IngestDate | Mon Oct 21 18:07:36 EDT 2024 Thu Sep 26 20:40:04 EDT 2024 Wed Oct 23 10:04:11 EDT 2024 Sat Oct 19 15:54:36 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Gastroenteropancreatic neuroendocrine tumor Sex-based differences Overall survival National cancer database |
| Language | English |
| License | Published by Elsevier Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c235t-e134f5fc770795876d045dc857a798dfaeda205b71b3fc38c9ed09109469e3a53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-4903-0422 0000-0003-4281-9666 |
| PMID | 39083906 |
| PQID | 3086954494 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_3086954494 crossref_primary_10_1016_j_jss_2024_07_012 pubmed_primary_39083906 elsevier_sciencedirect_doi_10_1016_j_jss_2024_07_012 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-10-01 |
| PublicationDateYYYYMMDD | 2024-10-01 |
| PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of surgical research |
| PublicationTitleAlternate | J Surg Res |
| PublicationYear | 2024 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Anaissie, DeLay, Wang, Hatzichristodoulou, Hellstrom (bib48) 2017; 6 Abdel-Rahman, Fazio (bib2) 2021; 50 Sherman, Tran, Howe (bib23) 2021; 28 Xu, Wang, Dai (bib37) 2021; 4 Wang, Chen, Fernandez-Del Castillo, Yilmaz, Deshpande (bib47) 2013; 26 Tran, Sherman, Suraju (bib21) 2022; 29 Boffa, Rosen, Mallin (bib24) 2017; 3 Kim, An, Lee (bib44) 2017; 51 Starzynska, Londzin-Olesik, Bałdys-Waligórska (bib18) 2017; 68 Mafficini, Scarpa (bib49) 2019; 40 White, Russell, Remmers (bib38) 2023; 15 DR (bib26) 1972; 34 Greenberg, Ivanov, Egan (bib39) 2022; 26 Kim, Lim, Moon (bib32) 2018; 26 Gadkar-Sable, Shah, Rosario, Sachdeva, Puri (bib41) 2005; 10 Viale, Doglioni, Gambacorta, Zamboni, Coggi, Bordi (bib5) 1992; 70 Kaplan EL, Meier (bib25) 1958; 53 Schmocker, Wright, Ding (bib12) 2021; 123 Dasari, Shen, Halperin (bib28) 2017; 3 Senturk, Acar, Yildirim, Çakir, Küçükkartallar, Vatansev (bib10) 2022; 51 Zimmermann, Lazar-Karsten, Keck (bib3) 2016; 36 Krzyszczyk, Acevedo, Davidoff (bib50) 2018; 6 Myers, Ershler, Tannenbaum, Barth (bib35) 1982; 96 Assi, Mukherjee, Kunz (bib9) 2020; 25 Risbridger, Davis, Birrell, Tilley (bib42) 2010; 10 Barros, Felismino, de Jesus (bib51) 2019; 30 Su, Chen, Jiang (bib46) 2022; 12 Arganini, Spinelli, Cecchini, Miccoli (bib36) 1989; 89 Satyaswaroop PG, Mortel, Mortel (bib4) 1984; 44 Rinke, Ambrosini, Dromain (bib19) 2023; 35 Garcia-Carbonero, Capdevila, Crespo-Herrero (bib29) 2010; 21 Howe (bib30) 2020; 11 Estrella, Ma, Milton (bib6) 2014; 43 Sonbol, Mazza, Mi (bib22) 2022; 27 Estrella, Broaddus, Mathews (bib43) 2014; 138 Cope, Srirajaskanthan (bib14) 2022; 24 Conte, George, Overman (bib17) 2016; 15 Katz, Levi, Twig (bib1) 2018; 143 Keshgegian, Wheeler (bib33) 1980; 45 Levin (bib40) 2005; 19 Gamboa, Liu, Lee (bib20) 2019; 120 Wagner, Oertelt-Prigione, Adjei (bib31) 2019; 30 Stathopoulos, Karvountzis, Yiotis (bib34) 1981; 305 Lewkowicz, Trofimiuk-Müldner, Wysocka (bib13) 2015; 125 Arnason, Sapp, Barnes, Drewniak, Abdolell, Rayson (bib45) 2011; 93 Blazevic, Iyer, van Velthuysen (bib7) 2022; 107 Pommergaard, Nielsen, Sorbye (bib11) 2021; 33 Modlin, Lye, Kidd (bib15) 2003; 97 Srirajaskanthan, Clement, Brown, Howard, Ramage (bib16) 2023; 15 Tran, Sherman, Howe (bib27) 2021; 28 Modlin, Gustafsson, Pavel, Svejda, Lawrence, Kidd (bib8) 2010; 92 Estrella (10.1016/j.jss.2024.07.012_bib6) 2014; 43 Schmocker (10.1016/j.jss.2024.07.012_bib12) 2021; 123 Abdel-Rahman (10.1016/j.jss.2024.07.012_bib2) 2021; 50 Wang (10.1016/j.jss.2024.07.012_bib47) 2013; 26 Conte (10.1016/j.jss.2024.07.012_bib17) 2016; 15 Katz (10.1016/j.jss.2024.07.012_bib1) 2018; 143 Kaplan EL (10.1016/j.jss.2024.07.012_bib25) 1958; 53 Risbridger (10.1016/j.jss.2024.07.012_bib42) 2010; 10 Arnason (10.1016/j.jss.2024.07.012_bib45) 2011; 93 Kim (10.1016/j.jss.2024.07.012_bib32) 2018; 26 Gamboa (10.1016/j.jss.2024.07.012_bib20) 2019; 120 Assi (10.1016/j.jss.2024.07.012_bib9) 2020; 25 Myers (10.1016/j.jss.2024.07.012_bib35) 1982; 96 Kim (10.1016/j.jss.2024.07.012_bib44) 2017; 51 Mafficini (10.1016/j.jss.2024.07.012_bib49) 2019; 40 Lewkowicz (10.1016/j.jss.2024.07.012_bib13) 2015; 125 Stathopoulos (10.1016/j.jss.2024.07.012_bib34) 1981; 305 Krzyszczyk (10.1016/j.jss.2024.07.012_bib50) 2018; 6 Satyaswaroop PG (10.1016/j.jss.2024.07.012_bib4) 1984; 44 Estrella (10.1016/j.jss.2024.07.012_bib43) 2014; 138 Arganini (10.1016/j.jss.2024.07.012_bib36) 1989; 89 Rinke (10.1016/j.jss.2024.07.012_bib19) 2023; 35 Modlin (10.1016/j.jss.2024.07.012_bib15) 2003; 97 Senturk (10.1016/j.jss.2024.07.012_bib10) 2022; 51 Boffa (10.1016/j.jss.2024.07.012_bib24) 2017; 3 Viale (10.1016/j.jss.2024.07.012_bib5) 1992; 70 Anaissie (10.1016/j.jss.2024.07.012_bib48) 2017; 6 Levin (10.1016/j.jss.2024.07.012_bib40) 2005; 19 Pommergaard (10.1016/j.jss.2024.07.012_bib11) 2021; 33 Tran (10.1016/j.jss.2024.07.012_bib27) 2021; 28 Modlin (10.1016/j.jss.2024.07.012_bib8) 2010; 92 Gadkar-Sable (10.1016/j.jss.2024.07.012_bib41) 2005; 10 Wagner (10.1016/j.jss.2024.07.012_bib31) 2019; 30 White (10.1016/j.jss.2024.07.012_bib38) 2023; 15 Dasari (10.1016/j.jss.2024.07.012_bib28) 2017; 3 Howe (10.1016/j.jss.2024.07.012_bib30) 2020; 11 Barros (10.1016/j.jss.2024.07.012_bib51) 2019; 30 Srirajaskanthan (10.1016/j.jss.2024.07.012_bib16) 2023; 15 Sherman (10.1016/j.jss.2024.07.012_bib23) 2021; 28 Zimmermann (10.1016/j.jss.2024.07.012_bib3) 2016; 36 Blazevic (10.1016/j.jss.2024.07.012_bib7) 2022; 107 Greenberg (10.1016/j.jss.2024.07.012_bib39) 2022; 26 DR (10.1016/j.jss.2024.07.012_bib26) 1972; 34 Cope (10.1016/j.jss.2024.07.012_bib14) 2022; 24 Su (10.1016/j.jss.2024.07.012_bib46) 2022; 12 Xu (10.1016/j.jss.2024.07.012_bib37) 2021; 4 Starzynska (10.1016/j.jss.2024.07.012_bib18) 2017; 68 Garcia-Carbonero (10.1016/j.jss.2024.07.012_bib29) 2010; 21 Keshgegian (10.1016/j.jss.2024.07.012_bib33) 1980; 45 Sonbol (10.1016/j.jss.2024.07.012_bib22) 2022; 27 Tran (10.1016/j.jss.2024.07.012_bib21) 2022; 29 |
| References_xml | – volume: 51 start-page: 388 year: 2017 end-page: 395 ident: bib44 article-title: Loss of progesterone receptor expression is an early tumorigenesis event associated with tumor progression and shorter survival in pancreatic neuroendocrine tumor patients publication-title: J Pathol Transl Med contributor: fullname: Lee – volume: 93 start-page: 249 year: 2011 end-page: 258 ident: bib45 article-title: Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors publication-title: Neuroendocrinology contributor: fullname: Rayson – volume: 15 start-page: 1863 year: 2023 ident: bib38 article-title: Sex differences in survival from neuroendocrine Neoplasia in england 2012-2018: a retrospective, population-based study publication-title: Cancers (Basel) contributor: fullname: Remmers – volume: 28 start-page: 2741 year: 2021 end-page: 2751 ident: bib27 article-title: The landmark series: management of small bowel neuroendocrine tumors publication-title: Ann Surg Oncol contributor: fullname: Howe – volume: 28 start-page: 2752 year: 2021 end-page: 2753 ident: bib23 article-title: ASO author reflections: indolent growth and small bowel neuroendocrine tumor management publication-title: Ann Surg Oncol contributor: fullname: Howe – volume: 35 year: 2023 ident: bib19 article-title: European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours publication-title: J Neuroendocrinol contributor: fullname: Dromain – volume: 138 start-page: 1027 year: 2014 end-page: 1036 ident: bib43 article-title: Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors publication-title: Arch Pathol Lab Med contributor: fullname: Mathews – volume: 26 start-page: 139 year: 2013 end-page: 147 ident: bib47 article-title: Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway publication-title: Mod Pathol contributor: fullname: Deshpande – volume: 50 start-page: 727 year: 2021 end-page: 731 ident: bib2 article-title: Sex-based differences in prognosis of patients with gastroenteropancreatic-neuroendocrine neoplasms: a population-based study publication-title: Pancreas contributor: fullname: Fazio – volume: 24 start-page: 257 year: 2022 end-page: 263 ident: bib14 article-title: Rectal neuroendocrine neoplasms: why is there a global variation? publication-title: Curr Oncol Rep contributor: fullname: Srirajaskanthan – volume: 53 start-page: 457 year: 1958 end-page: 481 ident: bib25 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc contributor: fullname: Meier – volume: 6 start-page: 183 year: 2017 end-page: 191 ident: bib48 article-title: Testosterone deficiency in adults and corresponding treatment patterns across the globe publication-title: Transl Androl Urol contributor: fullname: Hellstrom – volume: 19 start-page: 1951 year: 2005 end-page: 1959 ident: bib40 article-title: Integration of the extranuclear and nuclear actions of estrogen publication-title: Mol Endocrinol contributor: fullname: Levin – volume: 15 start-page: 2766 year: 2023 ident: bib16 article-title: Optimising outcomes and surveillance strategies of rectal neuroendocrine neoplasms publication-title: Cancers (Basel) contributor: fullname: Ramage – volume: 107 start-page: e1969 year: 2022 end-page: e1975 ident: bib7 article-title: Sexual dimorphism in small-intestinal neuroendocrine tumors: lower prevalence of mesenteric disease in premenopausal women publication-title: J Clin Endocrinol Metab contributor: fullname: van Velthuysen – volume: 125 start-page: 337 year: 2015 end-page: 346 ident: bib13 article-title: Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center publication-title: Pol Arch Med Wewn contributor: fullname: Wysocka – volume: 30 start-page: 1914 year: 2019 end-page: 1924 ident: bib31 article-title: Gender medicine and oncology: report and consensus of an ESMO workshop publication-title: Ann Oncol contributor: fullname: Adjei – volume: 33 year: 2021 ident: bib11 article-title: Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms publication-title: J Neuroendocrinol contributor: fullname: Sorbye – volume: 3 start-page: 1335 year: 2017 end-page: 1342 ident: bib28 article-title: Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States publication-title: JAMA Oncol contributor: fullname: Halperin – volume: 25 start-page: e276 year: 2020 end-page: e283 ident: bib9 article-title: Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the national cancer database publication-title: Oncologist contributor: fullname: Kunz – volume: 96 start-page: 383 year: 1982 ident: bib35 article-title: Tamoxifen and carcinoid tumor publication-title: Ann Intern Med contributor: fullname: Barth – volume: 21 start-page: 1794 year: 2010 end-page: 1803 ident: bib29 article-title: Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) publication-title: Ann Oncol contributor: fullname: Crespo-Herrero – volume: 30 start-page: 573 year: 2019 ident: bib51 article-title: HORMONET: study of tamoxifen in well differentiated neuroendocrine tumors and hormone receptor positive expression publication-title: Ann Oncol contributor: fullname: de Jesus – volume: 97 start-page: 934 year: 2003 end-page: 959 ident: bib15 article-title: A 5-decade analysis of 13,715 carcinoid tumors publication-title: Cancer contributor: fullname: Kidd – volume: 70 start-page: 2268 year: 1992 end-page: 2277 ident: bib5 article-title: Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestingal and respiratory tracts, and skin publication-title: Cancer contributor: fullname: Bordi – volume: 10 start-page: 205 year: 2010 end-page: 212 ident: bib42 article-title: Breast and prostate cancer: more similar than different publication-title: Nat Rev Cancer contributor: fullname: Tilley – volume: 143 start-page: 1876 year: 2018 end-page: 1883 ident: bib1 article-title: Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents publication-title: Int J Cancer contributor: fullname: Twig – volume: 51 start-page: 159 year: 2022 end-page: 163 ident: bib10 article-title: Clinicopathological characteristics of gastroenteropancreatic neuroendocrine tumors: 10 years of experience from a single center publication-title: Pancreas contributor: fullname: Vatansev – volume: 29 start-page: 75 year: 2022 end-page: 84 ident: bib21 article-title: Management of duodenal neuroendocrine tumors: surgical versus endoscopic mucosal resection publication-title: Ann Surg Oncol contributor: fullname: Suraju – volume: 4 year: 2021 ident: bib37 article-title: Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States publication-title: JAMA Netw Open contributor: fullname: Dai – volume: 6 start-page: 79 year: 2018 end-page: 100 ident: bib50 article-title: The growing role of precision and personalized medicine for cancer treatment publication-title: Technology (Singap World Sci) contributor: fullname: Davidoff – volume: 10 start-page: 2118 year: 2005 end-page: 2130 ident: bib41 article-title: Progesterone receptors: various forms and functions in reproductive tissues publication-title: Front Biosci contributor: fullname: Puri – volume: 123 start-page: 416 year: 2021 end-page: 424 ident: bib12 article-title: Duodenal, ampullary, and pancreatic neuroendocrine tumors: oncologic outcomes are driven by tumor biology and tissue of origin publication-title: J Surg Oncol contributor: fullname: Ding – volume: 44 start-page: 4006 year: 1984 end-page: 4010 ident: bib4 article-title: Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice publication-title: Cancer Res contributor: fullname: Mortel – volume: 26 start-page: 2321 year: 2022 end-page: 2329 ident: bib39 article-title: Sex-based clinicopathologic and survival differences among patients with pancreatic neuroendocrine tumors publication-title: J Gastrointest Surg contributor: fullname: Egan – volume: 34 start-page: 187 year: 1972 end-page: 220 ident: bib26 article-title: Regression models and life-tables publication-title: J R Statist Soc B contributor: fullname: DR – volume: 3 start-page: 1722 year: 2017 end-page: 1728 ident: bib24 article-title: Using the national cancer database for outcomes research: a review publication-title: JAMA Oncol contributor: fullname: Mallin – volume: 45 start-page: 293 year: 1980 end-page: 296 ident: bib33 article-title: Estrogen receptor protein in malignant carcinoid tumor: a report of 2 cases publication-title: Cancer contributor: fullname: Wheeler – volume: 15 start-page: e1 year: 2016 end-page: e7 ident: bib17 article-title: High-grade neuroendocrine colorectal carcinomas: a retrospective study of 100 patients publication-title: Clin Colorectal Cancer contributor: fullname: Overman – volume: 68 start-page: 250 year: 2017 end-page: 260 ident: bib18 article-title: Colorectal neuroendocrine neoplasms - management guidelines (recommended by the polish network of neuroendocrine tumours) publication-title: Endokrynol Pol contributor: fullname: Bałdys-Waligórska – volume: 12 year: 2022 ident: bib46 article-title: Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation publication-title: Front Oncol contributor: fullname: Jiang – volume: 26 start-page: 335 year: 2018 end-page: 342 ident: bib32 article-title: Sex differences in cancer: epidemiology, genetics and therapy publication-title: Biomol Ther (Seoul) contributor: fullname: Moon – volume: 92 start-page: 143 year: 2010 end-page: 157 ident: bib8 article-title: A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival publication-title: Neuroendocrinology contributor: fullname: Kidd – volume: 89 start-page: 209 year: 1989 end-page: 211 ident: bib36 article-title: Long term treatment with tamoxifen for metastatic carcinoid tumor publication-title: Acta Chir Belg contributor: fullname: Miccoli – volume: 36 start-page: 921 year: 2016 end-page: 924 ident: bib3 article-title: Expression pattern of CDX2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases publication-title: Anticancer Res contributor: fullname: Keck – volume: 43 start-page: 996 year: 2014 end-page: 1002 ident: bib6 article-title: Expression of estrogen-induced genes and estrogen receptor beta in pancreatic neuroendocrine tumors: implications for targeted therapy publication-title: Pancreas contributor: fullname: Milton – volume: 27 start-page: 573 year: 2022 end-page: 578 ident: bib22 article-title: Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER Database analysis publication-title: Oncologist contributor: fullname: Mi – volume: 305 start-page: 52 year: 1981 ident: bib34 article-title: Tamoxifen in carcinoid syndrome publication-title: N Engl J Med contributor: fullname: Yiotis – volume: 120 start-page: 1293 year: 2019 end-page: 1301 ident: bib20 article-title: Duodenal neuroendocrine tumors: somewhere between the pancreas and small bowel? publication-title: J Surg Oncol contributor: fullname: Lee – volume: 11 start-page: 182 year: 2020 end-page: 187 ident: bib30 article-title: Carcinoid tumors: past, present, and future publication-title: Indian J Surg Oncol contributor: fullname: Howe – volume: 40 start-page: 506 year: 2019 end-page: 536 ident: bib49 article-title: Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms publication-title: Endocr Rev contributor: fullname: Scarpa – volume: 24 start-page: 257 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib14 article-title: Rectal neuroendocrine neoplasms: why is there a global variation? publication-title: Curr Oncol Rep doi: 10.1007/s11912-021-01172-1 contributor: fullname: Cope – volume: 36 start-page: 921 year: 2016 ident: 10.1016/j.jss.2024.07.012_bib3 article-title: Expression pattern of CDX2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases publication-title: Anticancer Res contributor: fullname: Zimmermann – volume: 123 start-page: 416 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib12 article-title: Duodenal, ampullary, and pancreatic neuroendocrine tumors: oncologic outcomes are driven by tumor biology and tissue of origin publication-title: J Surg Oncol doi: 10.1002/jso.26285 contributor: fullname: Schmocker – volume: 15 start-page: 1863 year: 2023 ident: 10.1016/j.jss.2024.07.012_bib38 article-title: Sex differences in survival from neuroendocrine Neoplasia in england 2012-2018: a retrospective, population-based study publication-title: Cancers (Basel) doi: 10.3390/cancers15061863 contributor: fullname: White – volume: 3 start-page: 1722 year: 2017 ident: 10.1016/j.jss.2024.07.012_bib24 article-title: Using the national cancer database for outcomes research: a review publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.6905 contributor: fullname: Boffa – volume: 21 start-page: 1794 year: 2010 ident: 10.1016/j.jss.2024.07.012_bib29 article-title: Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) publication-title: Ann Oncol doi: 10.1093/annonc/mdq022 contributor: fullname: Garcia-Carbonero – volume: 30 start-page: 573 year: 2019 ident: 10.1016/j.jss.2024.07.012_bib51 article-title: HORMONET: study of tamoxifen in well differentiated neuroendocrine tumors and hormone receptor positive expression publication-title: Ann Oncol doi: 10.1093/annonc/mdz256.024 contributor: fullname: Barros – volume: 33 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib11 article-title: Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms publication-title: J Neuroendocrinol doi: 10.1111/jne.12967 contributor: fullname: Pommergaard – volume: 19 start-page: 1951 year: 2005 ident: 10.1016/j.jss.2024.07.012_bib40 article-title: Integration of the extranuclear and nuclear actions of estrogen publication-title: Mol Endocrinol doi: 10.1210/me.2004-0390 contributor: fullname: Levin – volume: 97 start-page: 934 year: 2003 ident: 10.1016/j.jss.2024.07.012_bib15 article-title: A 5-decade analysis of 13,715 carcinoid tumors publication-title: Cancer doi: 10.1002/cncr.11105 contributor: fullname: Modlin – volume: 6 start-page: 79 year: 2018 ident: 10.1016/j.jss.2024.07.012_bib50 article-title: The growing role of precision and personalized medicine for cancer treatment publication-title: Technology (Singap World Sci) contributor: fullname: Krzyszczyk – volume: 40 start-page: 506 year: 2019 ident: 10.1016/j.jss.2024.07.012_bib49 article-title: Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms publication-title: Endocr Rev doi: 10.1210/er.2018-00160 contributor: fullname: Mafficini – volume: 92 start-page: 143 year: 2010 ident: 10.1016/j.jss.2024.07.012_bib8 article-title: A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival publication-title: Neuroendocrinology doi: 10.1159/000319784 contributor: fullname: Modlin – volume: 70 start-page: 2268 year: 1992 ident: 10.1016/j.jss.2024.07.012_bib5 article-title: Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestingal and respiratory tracts, and skin publication-title: Cancer doi: 10.1002/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X contributor: fullname: Viale – volume: 120 start-page: 1293 year: 2019 ident: 10.1016/j.jss.2024.07.012_bib20 article-title: Duodenal neuroendocrine tumors: somewhere between the pancreas and small bowel? publication-title: J Surg Oncol doi: 10.1002/jso.25731 contributor: fullname: Gamboa – volume: 50 start-page: 727 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib2 article-title: Sex-based differences in prognosis of patients with gastroenteropancreatic-neuroendocrine neoplasms: a population-based study publication-title: Pancreas doi: 10.1097/MPA.0000000000001821 contributor: fullname: Abdel-Rahman – volume: 53 start-page: 457 year: 1958 ident: 10.1016/j.jss.2024.07.012_bib25 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc doi: 10.1080/01621459.1958.10501452 contributor: fullname: Kaplan EL – volume: 107 start-page: e1969 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib7 article-title: Sexual dimorphism in small-intestinal neuroendocrine tumors: lower prevalence of mesenteric disease in premenopausal women publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgac001 contributor: fullname: Blazevic – volume: 51 start-page: 159 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib10 article-title: Clinicopathological characteristics of gastroenteropancreatic neuroendocrine tumors: 10 years of experience from a single center publication-title: Pancreas doi: 10.1097/MPA.0000000000001981 contributor: fullname: Senturk – volume: 305 start-page: 52 year: 1981 ident: 10.1016/j.jss.2024.07.012_bib34 article-title: Tamoxifen in carcinoid syndrome publication-title: N Engl J Med doi: 10.1056/NEJM198107023050114 contributor: fullname: Stathopoulos – volume: 10 start-page: 205 year: 2010 ident: 10.1016/j.jss.2024.07.012_bib42 article-title: Breast and prostate cancer: more similar than different publication-title: Nat Rev Cancer doi: 10.1038/nrc2795 contributor: fullname: Risbridger – volume: 28 start-page: 2741 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib27 article-title: The landmark series: management of small bowel neuroendocrine tumors publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-09566-4 contributor: fullname: Tran – volume: 26 start-page: 2321 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib39 article-title: Sex-based clinicopathologic and survival differences among patients with pancreatic neuroendocrine tumors publication-title: J Gastrointest Surg doi: 10.1007/s11605-022-05345-6 contributor: fullname: Greenberg – volume: 12 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib46 article-title: Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation publication-title: Front Oncol doi: 10.3389/fonc.2022.955166 contributor: fullname: Su – volume: 6 start-page: 183 year: 2017 ident: 10.1016/j.jss.2024.07.012_bib48 article-title: Testosterone deficiency in adults and corresponding treatment patterns across the globe publication-title: Transl Androl Urol doi: 10.21037/tau.2016.11.16 contributor: fullname: Anaissie – volume: 15 start-page: e1 year: 2016 ident: 10.1016/j.jss.2024.07.012_bib17 article-title: High-grade neuroendocrine colorectal carcinomas: a retrospective study of 100 patients publication-title: Clin Colorectal Cancer doi: 10.1016/j.clcc.2015.12.007 contributor: fullname: Conte – volume: 30 start-page: 1914 year: 2019 ident: 10.1016/j.jss.2024.07.012_bib31 article-title: Gender medicine and oncology: report and consensus of an ESMO workshop publication-title: Ann Oncol doi: 10.1093/annonc/mdz414 contributor: fullname: Wagner – volume: 93 start-page: 249 year: 2011 ident: 10.1016/j.jss.2024.07.012_bib45 article-title: Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors publication-title: Neuroendocrinology doi: 10.1159/000326820 contributor: fullname: Arnason – volume: 43 start-page: 996 year: 2014 ident: 10.1016/j.jss.2024.07.012_bib6 article-title: Expression of estrogen-induced genes and estrogen receptor beta in pancreatic neuroendocrine tumors: implications for targeted therapy publication-title: Pancreas doi: 10.1097/MPA.0000000000000203 contributor: fullname: Estrella – volume: 28 start-page: 2752 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib23 article-title: ASO author reflections: indolent growth and small bowel neuroendocrine tumor management publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-09641-4 contributor: fullname: Sherman – volume: 96 start-page: 383 year: 1982 ident: 10.1016/j.jss.2024.07.012_bib35 article-title: Tamoxifen and carcinoid tumor publication-title: Ann Intern Med doi: 10.7326/0003-4819-96-3-383_1 contributor: fullname: Myers – volume: 89 start-page: 209 year: 1989 ident: 10.1016/j.jss.2024.07.012_bib36 article-title: Long term treatment with tamoxifen for metastatic carcinoid tumor publication-title: Acta Chir Belg contributor: fullname: Arganini – volume: 45 start-page: 293 year: 1980 ident: 10.1016/j.jss.2024.07.012_bib33 article-title: Estrogen receptor protein in malignant carcinoid tumor: a report of 2 cases publication-title: Cancer doi: 10.1002/1097-0142(19800115)45:2<293::AID-CNCR2820450216>3.0.CO;2-5 contributor: fullname: Keshgegian – volume: 34 start-page: 187 year: 1972 ident: 10.1016/j.jss.2024.07.012_bib26 article-title: Regression models and life-tables publication-title: J R Statist Soc B doi: 10.1111/j.2517-6161.1972.tb00899.x contributor: fullname: DR – volume: 143 start-page: 1876 year: 2018 ident: 10.1016/j.jss.2024.07.012_bib1 article-title: Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents publication-title: Int J Cancer doi: 10.1002/ijc.31589 contributor: fullname: Katz – volume: 29 start-page: 75 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib21 article-title: Management of duodenal neuroendocrine tumors: surgical versus endoscopic mucosal resection publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-10774-9 contributor: fullname: Tran – volume: 44 start-page: 4006 year: 1984 ident: 10.1016/j.jss.2024.07.012_bib4 article-title: Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice publication-title: Cancer Res contributor: fullname: Satyaswaroop PG – volume: 3 start-page: 1335 year: 2017 ident: 10.1016/j.jss.2024.07.012_bib28 article-title: Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.0589 contributor: fullname: Dasari – volume: 51 start-page: 388 year: 2017 ident: 10.1016/j.jss.2024.07.012_bib44 article-title: Loss of progesterone receptor expression is an early tumorigenesis event associated with tumor progression and shorter survival in pancreatic neuroendocrine tumor patients publication-title: J Pathol Transl Med doi: 10.4132/jptm.2017.03.19 contributor: fullname: Kim – volume: 35 year: 2023 ident: 10.1016/j.jss.2024.07.012_bib19 article-title: European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours publication-title: J Neuroendocrinol doi: 10.1111/jne.13309 contributor: fullname: Rinke – volume: 138 start-page: 1027 year: 2014 ident: 10.1016/j.jss.2024.07.012_bib43 article-title: Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2013-0195-OA contributor: fullname: Estrella – volume: 26 start-page: 335 year: 2018 ident: 10.1016/j.jss.2024.07.012_bib32 article-title: Sex differences in cancer: epidemiology, genetics and therapy publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2018.103 contributor: fullname: Kim – volume: 4 year: 2021 ident: 10.1016/j.jss.2024.07.012_bib37 article-title: Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.24750 contributor: fullname: Xu – volume: 68 start-page: 250 year: 2017 ident: 10.1016/j.jss.2024.07.012_bib18 article-title: Colorectal neuroendocrine neoplasms - management guidelines (recommended by the polish network of neuroendocrine tumours) publication-title: Endokrynol Pol contributor: fullname: Starzynska – volume: 11 start-page: 182 year: 2020 ident: 10.1016/j.jss.2024.07.012_bib30 article-title: Carcinoid tumors: past, present, and future publication-title: Indian J Surg Oncol doi: 10.1007/s13193-020-01079-6 contributor: fullname: Howe – volume: 10 start-page: 2118 year: 2005 ident: 10.1016/j.jss.2024.07.012_bib41 article-title: Progesterone receptors: various forms and functions in reproductive tissues publication-title: Front Biosci doi: 10.2741/1685 contributor: fullname: Gadkar-Sable – volume: 26 start-page: 139 year: 2013 ident: 10.1016/j.jss.2024.07.012_bib47 article-title: Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway publication-title: Mod Pathol doi: 10.1038/modpathol.2012.143 contributor: fullname: Wang – volume: 15 start-page: 2766 year: 2023 ident: 10.1016/j.jss.2024.07.012_bib16 article-title: Optimising outcomes and surveillance strategies of rectal neuroendocrine neoplasms publication-title: Cancers (Basel) doi: 10.3390/cancers15102766 contributor: fullname: Srirajaskanthan – volume: 27 start-page: 573 year: 2022 ident: 10.1016/j.jss.2024.07.012_bib22 article-title: Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER Database analysis publication-title: Oncologist doi: 10.1093/oncolo/oyac049 contributor: fullname: Sonbol – volume: 25 start-page: e276 year: 2020 ident: 10.1016/j.jss.2024.07.012_bib9 article-title: Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the national cancer database publication-title: Oncologist doi: 10.1634/theoncologist.2019-0466 contributor: fullname: Assi – volume: 125 start-page: 337 year: 2015 ident: 10.1016/j.jss.2024.07.012_bib13 article-title: Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center publication-title: Pol Arch Med Wewn doi: 10.20452/pamw.2832 contributor: fullname: Lewkowicz |
| SSID | ssj0002973 |
| Score | 2.4686923 |
| Snippet | Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 53 |
| SubjectTerms | Gastroenteropancreatic neuroendocrine tumor National cancer database Overall survival Sex-based differences |
| Title | Association Between Female Sex and Better Survival in Gastroenteropancreatic Neuroendocrine Tumors |
| URI | https://dx.doi.org/10.1016/j.jss.2024.07.012 https://www.ncbi.nlm.nih.gov/pubmed/39083906 https://www.proquest.com/docview/3086954494 |
| Volume | 302 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFH_s4-JFFL_mx4jgSahrm6RNjzqcU3GXTfAW2iSFDWyl28CTf7sv_Rh6mAePDZSGX9Lf-z3y3i8AVyhBA-25iSOCNHKYwJxVUKocJMLEMmaSlr0wL5Ng_Mqe3vhbC4ZNL4wtq6y5v-L0kq3rkUGN5uBjPrc9vhh-hD26KxtMwzZ0MRwx1oHu7ePzeLIhZHs9U2Mabl9oDjfLMq_F0pp2-6y08PT8beFpm_wsw9BoD3Zr_UhuqynuQ8tkB5D8AJncVZVXZGTekfzJ1HySONN2GCEk0zVyA-4uMs_IQ7xcFbk15Swwdc4q_ahI6ddhMp0r2xlIZuv3vFgewuvofjYcO_XlCY7yKV85xqMs5akKrQUeR87TKN60EjyMw0joNDY69l2ehF5CU0WFioy22iHCfNnQmNMj6GR5Zk6AoMQJWVJa4ynm60Boxrjx_FAYLZSrenDdYCY_Ko8M2RSPLSQCLC3A0g0lAtwD1qAqfy20RA7_67XLZgUk_gD2VCPOTL5eSopJWcQZi1gPjqul2cyCRqgwIzc4_d9Hz2DHPlW1e-fQWRVrc4EaZJX0oX3z5fXrnfYN5dLZ3A |
| link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELVKOcAFgdjKaiROSIEkthPnCBWlbL20SNysxHakIpFUXSROfDszTsJygANXJ1GsN9bzG3nmmZBTkKCRCfzMk1GeeFxCzioZ0x4QYYaMmeWuF-ZxEPWf-N2zeG6RbtMLg2WVNfdXnO7Yuh65qNG8mIzH2OML24_EozvXYBovkWVUA1jXdf7-VeeBlzM1luH4enO06Yq8XmZo2R1yZ-AZhL9tTr-JT7cJ9dbJWq0e6WU1wQ3SssUmyb5BTK-quivas69A_XRo32haGBwGAOlwAcwAa4uOC3qTzubTEi05p5A4F5V61NS5ddjClBr7Aulo8VpOZ1vkqXc96va9-uoET4dMzD0bMJ6LXMdogCeA8QxIN6OliNM4kSZPrUlDX2RxkLFcM6kTa1A5JJAtW5YKtk3aRVnYXUJB4MQ8c8Z4mocmkoZzYYMwltZI7esOOWswU5PKIUM1pWMvCgBWCLDyYwUAdwhvUFU_wqyAwf_67KSJgILlj2caaWHLxUwxSMkSwXnCO2SnCs3nLFgC-jLxo73__fSYrPRHjw_q4XZwv09W8UlVxXdA2vPpwh6CGplnR261fQDSPNqx |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+Between+Female+Sex+and+Better+Survival+in+Gastroenteropancreatic+Neuroendocrine+Tumors&rft.jtitle=The+Journal+of+surgical+research&rft.au=Chang%2C+Jeremy&rft.au=Suraju%2C+Mohammed+O.&rft.au=Tran%2C+Catherine+G.&rft.au=Chan%2C+Carlos+H.F.&rft.date=2024-10-01&rft.issn=0022-4804&rft.volume=302&rft.spage=53&rft.epage=63&rft_id=info:doi/10.1016%2Fj.jss.2024.07.012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jss_2024_07_012 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-4804&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-4804&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-4804&client=summon |